Manulife (Manufacturers Life Insurance)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $717K | Buy |
22,686
+532
| +2% | +$16.8K | ﹤0.01% | 1975 |
|
2025
Q1 | $735K | Buy |
22,154
+2,769
| +14% | +$91.9K | ﹤0.01% | 1950 |
|
2024
Q4 | $667K | Buy |
19,385
+2,144
| +12% | +$73.8K | ﹤0.01% | 2092 |
|
2024
Q3 | $690K | Sell |
17,241
-211
| -1% | -$8.44K | ﹤0.01% | 2111 |
|
2024
Q2 | $527K | Sell |
17,452
-477
| -3% | -$14.4K | ﹤0.01% | 2196 |
|
2024
Q1 | $602K | Buy |
17,929
+1,415
| +9% | +$47.5K | ﹤0.01% | 2123 |
|
2023
Q4 | $533K | Sell |
16,514
-568
| -3% | -$18.3K | ﹤0.01% | 2143 |
|
2023
Q3 | $560K | Buy |
17,082
+3,295
| +24% | +$108K | ﹤0.01% | 2077 |
|
2023
Q2 | $485K | Buy |
13,787
+2,526
| +22% | +$88.9K | ﹤0.01% | 2056 |
|
2023
Q1 | $368K | Buy |
11,261
+202
| +2% | +$6.6K | ﹤0.01% | 2200 |
|
2022
Q4 | $609K | Buy |
11,059
+290
| +3% | +$16K | ﹤0.01% | 1861 |
|
2022
Q3 | $477K | Sell |
10,769
-192
| -2% | -$8.5K | ﹤0.01% | 2012 |
|
2022
Q2 | $535K | Buy |
10,961
+1,011
| +10% | +$49.3K | ﹤0.01% | 2013 |
|
2022
Q1 | $484K | Sell |
9,950
-2,023
| -17% | -$98.4K | ﹤0.01% | 2225 |
|
2021
Q4 | $511 | Buy |
11,973
+500
| +4% | +$21 | ﹤0.01% | 2240 |
|
2021
Q3 | $440K | Sell |
11,473
-1,094
| -9% | -$42K | ﹤0.01% | 2386 |
|
2021
Q2 | $355K | Buy |
+12,567
| New | +$355K | ﹤0.01% | 2688 |
|